Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms
The Effect of a Structured Combined Exercise Program on Heart Rate Variability and Menopausal Symptoms in Postmenopausal Women: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether a structured combined exercise program can improve heart health, menopausal symptoms, sleep quality, and quality of life in postmenopausal women aged 45 to 65 years. The main questions it aims to answer are: Does the exercise program improve heart rate variability, which shows how well the heart is controlled by the nervous system? Does the exercise program lower menopausal symptoms? Does the exercise program improve sleep quality and quality of life? Researchers will compare women who join the exercise program with women who continue their usual daily activities. Participants in the exercise group will take part in a supervised exercise program for 12 weeks. They will exercise 2 days each week. Each session will last 45 minutes and will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises. Participants in the control group will continue their usual daily activities during the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2026
CompletedFirst Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMay 29, 2026
May 1, 2026
2 months
May 12, 2026
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heart Rate Variability
Cardiac autonomic nervous system function will be assessed using heart rate variability parameters including standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), low-frequency power (LF), high-frequency power (HF), and low-frequency/high-frequency ratio (LF/HF ratio).
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
Secondary Outcomes (5)
Menopause Rating Scale
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
Sleep Quality
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
Menopause-Specific Quality of Life
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
Depressive Symptoms
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
Hot Flash Frequency and Severity
Daily throughout the 12-week intervention period and daily during the 8-week post-intervention follow-up period
Study Arms (2)
Exercise Group
EXPERIMENTALParticipants will receive a 12-week structured combined exercise program performed twice weekly under physiotherapist supervision.
Control Group
NO INTERVENTIONParticipants in the control group will continue their usual daily activities and will not receive any structured exercise intervention during the study period. At the end of the study, participants in the control group will be informed about the exercise program, and volunteers will be offered the opportunity to participate in the program in accordance with ethical considerations.
Interventions
The intervention consists of a supervised 12-week structured combined exercise program performed twice weekly. Each 45-minute session includes warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises.
Eligibility Criteria
You may qualify if:
- Women in the postmenopausal period
- Aged between 45 and 65 years
- Able to communicate and cooperate with the researchers
- Not participating in another structured exercise program
- Willing to participate voluntarily in the study
You may not qualify if:
- Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease
- Hormone replacement therapy use during the study period
- Cognitive impairment affecting participation
- Uncontrolled hypertension or other unstable medical conditions
- Regular participation in structured exercise training within the last 6 months
- Smoking or alcohol use that may affect heart rate variability measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fenerbahce University
Istanbul, Atasehir, Turkey (Türkiye)
Related Publications (1)
Yilmaz Babacan G, Guler Cekic S, Algun ZC, Durmusoglu AF. Effects of exercise training on vasomotor symptoms and quality of life in postmenopausal women: a randomized controlled trial. BMC Womens Health. 2025 Dec 22;25(1):612. doi: 10.1186/s12905-025-04231-y.
PMID: 41430672RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 12, 2026
First Posted
May 29, 2026
Study Start
April 27, 2026
Primary Completion
July 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
May 29, 2026
Record last verified: 2026-05